openPR Logo
Press release

Aurora Kinase B ELISA Kit Market to Reach USD 250 Million by 2034, Growing at a 6% CAGR

06-10-2025 08:47 AM CET | Health & Medicine

Press release from: Exactitude Consultancy

Aurora Kinase B ELISA Kit

Aurora Kinase B ELISA Kit

As of 2024, the global Aurora Kinase B ELISA Kit market is valued at approximately $150 million. This sector is poised for substantial growth, with projections indicating a market value of around $250 million by 2034. This trajectory suggests a Compound Annual Growth Rate (CAGR) of approximately 6% during the forecast period from 2025 to 2034.

Exactitude Consultancy., Ltd. released a research report offers a comprehensive examination of the various processes and materials used in the production of Aurora Kinase B ELISA Kit market goods. The market study excludes key regions that are accelerating marketization. This section also gives the extent of different market segments and applications that could have an impact on the market in the future. Current trends and historical turning points form the basis of the enormous amount of data. The report includes information on market trends and development, growth drivers, emerging technologies, and the investment structure of the Aurora Kinase B ELISA Kit market.

This report is also available in the following languages : Japanese (オーロラキナーゼB ELISAキット), Korean (오로라 키나제 B ELISA 키트), Chinese (Aurora激酶B ELISA试剂盒), French (Kit ELISA Aurora Kinase B), German (Aurora Kinase B ELISA Kit), and Italian (Kit ELISA Aurora Kinase B), etc.

Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/66243

Key Companies:
Thermo Fisher Scientific, Bio-Rad Laboratories, Abcam plc, R&D Systems (part of Bio-Techne), Sigma-Aldrich (part of Merck KGaA), Santa Cruz Biotechnology, Becton, Dickinson and Company, GeneTex, Enzo Life Sciences, Lifespan Biosciences, Cloud-Clone Corp, ANTIBODYSTORE, RayBiotech, Abeam Bioscience, Cell Signaling Technology

Market Segmentation
By Product Type
Complete Kits
Reagents
Accessories

By Application
Cancer Research
Drug Development
Diagnostics

By End User
Academic Research Institutes
Pharmaceutical Companies
Clinical Laboratories

By Technology
Colorimetric
Chemiluminescent
Fluorescent

By Distribution Channel
Direct Sales
Online Sales
Distributors

Explore Full Report here: https://exactitudeconsultancy.com/reports/66243/aurora-kinase-b-elisa-kit-market

If opting for the Global version of Aurora Kinase B ELISA Kit Market; then the below country analysis would be included:

- North America (the USA, Canada, and Mexico)
- Europe (Germany, France, the United Kingdom, Netherlands, Italy, Nordic Nations, Spain, Switzerland, and the Rest of Europe)
- Asia-Pacific (China, Japan, Australia, New Zealand, South Korea, India, Southeast Asia, and the Rest of APAC)
- South America (Brazil, Argentina, Chile, Colombia, the Rest of the countries, etc.)
- the Middle East and Africa (Saudi Arabia, United Arab Emirates, Israel, Egypt, Turkey, Nigeria, South Africa, Rest of MEA)

Buy Now @ https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=66243

The report provides insights on the following pointers:
Market Penetration: Comprehensive information on the product portfolios of the top players in the Aurora Kinase B ELISA Kit market.
Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market.
Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies.
Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Aurora Kinase B ELISA Kit market.

Get Your Exclusive Offer with up to 30% Discount : https://exactitudeconsultancy.com/check-discount/66243

Reasons To Buy The Aurora Kinase B ELISA Kit Market Report:

➼ In-depth analysis of the market on the global and regional levels.
➼ Major changes in market dynamics and competitive landscape.
➼ Segmentation on the basis of type, application, geography, and others.
➼ Historical and future market research in terms of size, share growth, volume, and sales.
➼ Major changes and assessment in market dynamics and developments.
➼ Emerging key segments and regions
➼ Key business strategies by major market players and their key methods

Our team is available 24/7 to assist and support our customers through reliable research.

Customization
-20% free customization.
-Five Countries can be added as per your choice.
-Five Companies can added as per your choice.
-Free customization up to 40 hours.
-Post-sales support for 1 year from the date of delivery.

Other Reports:

Surgical Dressing Tapes Market
https://exactitudeconsultancy.com/reports/65724/surgical-dressing-tapes-market

Disposable Ultraviolet Dialysis Blood Container Market
https://exactitudeconsultancy.com/reports/65745/disposable-ultraviolet-dialysis-blood-container-market

Medical Gas Making Equipment Market
https://exactitudeconsultancy.com/reports/65765/medical-gas-making-equipment-market

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

https://exactitudeconsultancy.com/

Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Aurora Kinase B ELISA Kit Market to Reach USD 250 Million by 2034, Growing at a 6% CAGR here

News-ID: 4058693 • Views:

More Releases from Exactitude Consultancy

Relapsed/Refractory Acute Myeloid Leukemia Market is expected to reach USD 6.1 billion by 2034
Relapsed/Refractory Acute Myeloid Leukemia Market is expected to reach USD 6.1 b …
Acute myeloid leukemia (AML) is a highly aggressive hematologic malignancy characterized by the rapid proliferation of abnormal myeloid cells in the bone marrow and blood. Despite advances in frontline therapies, relapse is common, and many patients develop refractory disease, leaving limited treatment options and poor survival outcomes. Relapsed/refractory AML (R/R AML) remains a major unmet clinical need. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71571 In recent years, however, the
Retinoblastoma Market to Reach USD 1.2 Billion by 2034
Retinoblastoma Market to Reach USD 1.2 Billion by 2034
Retinoblastoma is a rare pediatric eye cancer that originates in the retina and primarily affects children under five years of age. It accounts for around 3% of all childhood cancers but is the most common intraocular malignancy in children. With improved awareness, early screening, and advances in treatment, survival rates in developed nations exceed 90%. However, challenges remain in low- and middle-income countries where delayed diagnosis and limited access to
Severe Toxicities in Lymphoma Market Projected to Reach USD 3.7 Billion by 2034
Severe Toxicities in Lymphoma Market Projected to Reach USD 3.7 Billion by 2034
Lymphoma, a group of blood cancers affecting the lymphatic system, is broadly classified into Hodgkin's lymphoma (HL) and non-Hodgkin's lymphoma (NHL). While survival outcomes have improved significantly with chemotherapy, radiotherapy, targeted agents, and immunotherapies, many patients experience severe toxicities as side effects of treatment. These toxicities - ranging from cytokine release syndrome (CRS) and neurotoxicity in CAR-T therapy to myelosuppression, infections, and organ toxicities from chemotherapy and immunomodulators - can
Soft Tissue Neoplasms Market to Reach USD 6.0 Billion by 2034
Soft Tissue Neoplasms Market to Reach USD 6.0 Billion by 2034
Soft tissue neoplasms are abnormal growths arising from connective tissues, including muscles, fat, nerves, tendons, and blood vessels. While some are benign, malignant forms such as soft tissue sarcomas (STS) pose serious clinical challenges due to their aggressive nature, rarity, and diverse histological subtypes. Representing about 1% of all adult cancers, these neoplasms require a wide spectrum of treatments ranging from surgery and radiotherapy to chemotherapy and novel targeted therapies. Download

All 5 Releases


More Releases for ELISA

12-23-2024 | Health & Medicine
Getnews
Amerigo Scientific Enriches ELISA Kit Portfolio with SAN HQ ELISA Kit Developed …
Amerigo Scientific is excited to enrich its ELISA kit portfolio by adding the SAN HQ ELISA Kit, developed for the quantitative determination of SAN HQ levels. Image: https://www.globalnewslines.com/uploads/2024/12/070b83e0b5f352d743d44df18a43d0d3.jpg As a leading distributor of life science products and instruments, Amerigo Scientific is excited to enrich its ELISA kit portfolio by adding SAN HQ ELISA kits [https://www.amerigoscientific.com/san-hq-elisa-kit-item-90408.html], which are specifically developed for the quantitative determination of SAN HQ levels, providing researchers with enhanced analytical
ELISA Tests Market Size, Share, Trends, Demand, Growth, Challenges and Competiti …
Market Analysis and Insights : Global ELISA Tests Market The ELISA tests market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 7.23% in the forecast period of 2021 to 2028. The growing incidence of infectious diseases will help in escalating the growth of the ELISA tests market. Enzyme-Linked Immunosorbent Assay (ELISA)
ELISA Technologies Market 2022 | Detailed Report
The market report delivers an all-inclusive analysis of the market structure along with a forecast of the various segments and sub-segments of the ELISA Technologies industry. This wide-ranging market research report acts as a backbone for the success of business in any niche. The ELISA Technologies market survey report has been prepared by conducting market research in a systematic manner. Moreover, the ELISA Technologies report includes a professional in-depth study
Global ELISA Analyzers Market Research Report
This report studies the global ELISA Analyzers market status and forecast, categorizes the global ELISA Analyzers market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Thermo Fisher PerkinElmer Tecan BioTek EUROIMMUN DiaSorin BIO-RAD Molecular Devices Dynex Technologies BMG Labtech KHB Promega Trinity
Global ELISA Processors Market Research Report 2018
In this report, the global ELISA Processors market is valued at USD million in 2017 and is expected to reach USD million by the end of 2025, growing at a CAGR between 2017 and 2025. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of ELISA Processors in these regions, from 2013 to 2025 (forecast), covering
Global Elisa Kits Market Trend and Forecast 2025
This study focuses on the production side and consumption side of ELISA Kits, presents the global ELISA Kits market size by manufacturers, regions, type and application, history breakdown data from 2013 to 2018, and forecast to 2025. In terms of production side, this report researches the ELISA Kits capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and product type. In terms of consumption side, this